Gene: UBE2A
Official Full Name: ubiquitin conjugating enzyme E2 Aprovided by HGNC
Gene Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, ubiquitin-conjugating enzymes, and ubiquitin-protein ligases. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is required for post-replicative DNA damage repair, and may play a role in transcriptional regulation. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34878 | UBE2A Knockout cell line (HeLa) | Human | UBE2A | 1:3~1:6 | Negative | Online Inquiry |
KO34879 | UBE2A Knockout cell line (HCT 116) | Human | UBE2A | 1:2~1:4 | Negative | Online Inquiry |
KO34880 | UBE2A Knockout cell line (HEK293) | Human | UBE2A | 1:3~1:6 | Negative | Online Inquiry |
KO34881 | UBE2A Knockout cell line (A549) | Human | UBE2A | 1:3~1:4 | Negative | Online Inquiry |
UBE2A Gene Knockout Cell Lines are specialized cellular models engineered to silence the UBE2A gene, which encodes a ubiquitin-conjugating enzyme integral to protein ubiquitination—a process crucial for protein degradation, signaling, and cellular homeostasis. By utilizing CRISPR-Cas9 technology, these cell lines enable researchers to investigate the direct consequences of UBE2A depletion on various biological pathways and cellular functions.
The primary mechanism of action revolves around the disruption of the UBE2A gene, which leads to an altered ubiquitin-proteasome system. This modification allows scientists to observe the downstream effects on proteostasis, particularly in relation to misfolded proteins and cellular stress responses. UBE2A is implicated in several diseases, including neurodegenerative disorders and cancers, making these knockout cell lines invaluable for advancing our understanding of disease mechanisms and potential therapeutic targets.
In research and clinical settings, UBE2A Gene Knockout Cell Lines offer significant advantages over traditional study methods, such as transient transfection or pharmacological inhibition. They provide a stable genetic background in which to examine the long-term effects of gene loss, facilitating the exploration of compensatory mechanisms and gene interactions. Furthermore, these cell lines demonstrate reproducibility and reliability, which are essential for obtaining valid experimental results.
For researchers and clinicians, the ability to precisely manipulate UBE2A expression opens new avenues for innovative therapies and drug discovery. It empowers users to delineate the functional roles of UBE2A in disease contexts, paving the way for targeted interventions.
Our company specializes in pioneering genetic engineering solutions, providing high-quality, validated biological products that support groundbreaking research initiatives. With our expertise, we ensure that researchers have access to the most reliable and effective tools to deepen their investigations into the complexities of cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.